SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Mar-24 4:46 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 126,981 | $5.60 | $711,094.00 | (8%) 1.65M to 1.52M | |
22-Feb-24 4:25 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 661,538 | -- | -- | 67% 987.56K to 1.65M | |
06-Mar-23 4:27 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 667,407 | -- | -- | 192% 348.31K to 1.02M | |
06-Mar-23 4:27 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Sale | 32,750 | $8.94 | $292,785.00 | (3%) 1.02M to 982.97K | |
26-May-22 5:22 PM View: | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 79,645 | $5.60 | $446,012.00 | (100%) 79.64K to 0 | |
22-Mar-22 5:12 PM View: | BioDelivery Sciences Intern... (BDSI) | 22-Mar-22 | Disposition (other) | 105,034 | -- | -- | (100%) 105.03K to 0 | |
04-Mar-22 4:11 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-22 | Grant | 28,300 | -- | -- | 206% 13.73K to 42.03K | |
04-Mar-22 4:11 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-22 | Sale | 9,068 | $12.01 | $108,907.00 | (22%) 42.03K to 32.97K | |
31-Jan-22 6:02 PM View: | BioDelivery Sciences Intern... (BDSI) | 27-Jan-22 | Option Exercise | 10,246 | -- | -- | 11% 94.79K to 105.03K | |
10-Aug-21 6:17 PM View: | BioDelivery Sciences Intern... (BDSI) | 06-Aug-21 | Option Exercise | 35,000 | -- | -- | 59% 59.79K to 94.79K | |
14-Jun-21 6:22 PM View: | Antares Pharma Inc. (ATRS) | 10-Jun-21 | Grant | 25,452 | $4.42 | $112,498.00 | 47% 54.19K to 79.64K | < 1% |
12-May-21 4:32 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 11-May-21 | Market Purchase | 5,125 | $10.71 | $54,891.10 | 62% 8.33K to 13.45K | 11% |
11-Aug-20 5:03 PM View: | BioDelivery Sciences Intern... (BDSI) | 07-Aug-20 | Option Exercise | 35,000 | -- | -- | 141% 24.79K to 59.79K | |
15-Jun-20 7:02 PM View: | Antares Pharma Inc. (ATRS) | 11-Jun-20 | Grant | 30,220 | $2.73 | $82,500.60 | 126% 23.97K to 54.19K | 41% |
15-Aug-19 4:25 PM View: | BioDelivery Sciences Intern... (BDSI) | 13-Aug-19 | Option Exercise | 21,144 | -- | -- | 580% 3.64K to 24.79K | |
14-Jun-19 5:49 PM View: | Antares Pharma Inc. (ATRS) | 13-Jun-19 | Grant | 23,973 | $2.92 | $70,001.20 | 100% 0 to 23.97K | 32% |
29-May-19 4:29 PM View: | Avalo Therapeutics, Inc. (CERC) | 24-May-19 | Disposition | 300,000 | -- | -- | (73%) 412.5K to 112.5K | |
16-Aug-18 5:01 PM View: | BioDelivery Sciences Intern... (BDSI) | 14-Aug-18 | Option Exercise | 3,644 | -- | -- | 100% 0 to 3.64K | |
21-May-18 7:10 PM View: | Avalo Therapeutics, Inc. (CERC) | 18-May-18 | Market Purchase | 12,500 | $3.98 | $49,750.00 | 3% 400.0K to 412.5K | (25%) |
29-Mar-18 6:51 PM View: | Avalo Therapeutics, Inc. (CERC) | 27-Mar-18 | Grant | 400,000 | -- | -- | 100% 0 to 400.0K | |
13-Feb-18 4:54 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 129,729 | $18.00 | $2,335,120.00 | (100%) 129.73K to 0 | |
04-Jan-18 5:16 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 171 | $9.10 | $1,556.10 | 4% 4.62K to 4.79K | |
05-Oct-17 4:32 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 659 | $9.10 | $5,996.90 | 17% 3.96K to 4.62K | |
07-Jul-17 4:45 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 673 | $8.93 | $6,009.89 | 20% 3.29K to 3.96K | |
10-May-17 4:02 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Mar-17 | Grant | 641 | $9.35 | $5,993.35 | 24% 2.65K to 3.29K | |
08-Mar-17 5:02 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 06-Mar-17 | Grant | 125,000 | -- | -- | 100% 0 to 125.0K | |
06-Jan-17 4:02 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-16 | Grant | 135 | $10.46 | $1,412.10 | 5% 2.51K to 2.65K | |
30-Nov-16 4:01 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 29-Nov-16 | Option Exercise | 82,459 | $6.75 | $556,598.00 | 3281% 2.51K to 84.97K | |
30-Nov-16 4:01 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 29-Nov-16 | Market Option Sale | 82,459 | $16.75 | $1,381,190.00 | (97%) 84.97K to 2.51K | (6%) |
30-Nov-16 4:01 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 28-Nov-16 | Option Exercise | 117,541 | $6.75 | $793,402.00 | 4677% 2.51K to 120.05K | |
30-Nov-16 4:01 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 28-Nov-16 | Market Option Sale | 117,541 | $16.91 | $1,987,620.00 | (98%) 120.05K to 2.51K | (5%) |
21-Oct-16 4:06 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-16 | Grant | 640 | $9.38 | $6,003.20 | 34% 1.87K to 2.51K | |
18-Jul-16 5:05 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-16 | Grant | 751 | $9.32 | $6,999.32 | 67% 1.12K to 1.87K | |
16-Jun-16 4:31 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Mar-16 | Grant | 646 | $9.29 | $6,001.34 | 136% 0.48K to 1.12K | |
04-Mar-16 5:56 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-15 | Grant | 476 | $14.70 | $6,997.20 | 100% 0 to 0.48K |